Expert consensus on the safety prevention and control of nuclear medicine diagnosis and treatment during the outbreak of COVID-19 (1st edition): (translated from Chinese version)
In December 2019, an infectious disease caused by a new type of coronavirus infection was prevalent in Wuhan and across the country. On January 20, 2020, the National Health Commission of the People’s Republic of China issued No.1 Announcement, which incorporated the novel coronavirus pneumonia into...
Gespeichert in:
| Veröffentlicht in: | European journal of nuclear medicine and molecular imaging 2021-04, Vol.48 (4), p.1134-1143 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1143 |
|---|---|
| container_issue | 4 |
| container_start_page | 1134 |
| container_title | European journal of nuclear medicine and molecular imaging |
| container_volume | 48 |
| creator | Lan, Xiaoli Long, Yu Shao, Fuqiang Song, Yangminghui |
| description | In December 2019, an infectious disease caused by a new type of coronavirus infection was prevalent in Wuhan and across the country. On January 20, 2020, the National Health Commission of the People’s Republic of China issued No.1 Announcement, which incorporated the novel coronavirus pneumonia into the Class B infectious disease according to the Law on Prevention and Control of Infectious Disease, but the disease should be adopted in the management of Class A infectious disease. In order to effectively control the source of infection, cut off the transmission route, protect the susceptible population, ensure the medical quality and medical safety, perform epidemic prevention and control, and comprehensively guarantee the life safety and physical health of medical staff, patients, and family members, it is very important to organize and carry out nuclear medicine diagnosis and treatment scientifically and safely. According to the national prevention and control policy, Chinese Society of Nuclear Medicine and editorial board of the
Chinese Journal of Nuclear Medicine and Molecular Imaging
organized professionals to formulate the expert consensus on the safety prevention process of nuclear medicine imaging and nuclide therapy during the period of new coronavirus infection. |
| doi_str_mv | 10.1007/s00259-020-04900-0 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7779900</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2475096259</sourcerecordid><originalsourceid>FETCH-LOGICAL-c532t-6cc99b8854ced875b16e3157fd775c3332666392c42302e833834c069e2312293</originalsourceid><addsrcrecordid>eNp9kk1v1DAQhiMEoqXwBzggS1yWQ8AfSRxzQEJLWypV6gW4Wl5nsuuS2IvHWdG_xS_E2S3Lx4GLbdnPvDPjeYviOaOvGaXyDVLKa1VSTktaKZrXB8Upa5gqJW3Vw-NZ0pPiCeItpazlrXpcnAghVEVle1r8OP--hZiIDR7B44QkeJI2QND0kO7INsIOfHL51vhuxlIMAwk98ZMdwEQyQues80A6Z9Y-oMM9mSKYNOZQ0k3R-fVeNExple-_zvHLmy9XH0qmyIJhIllkTvLqLVmkaDwOJkFH-hhGstxkdQSyg4gz8rR41JsB4dn9flZ8vjj_tPxYXt9cXi3fX5e2FjyVjbVKrdq2rix0raxXrAHBatl3UtY2_wBvmkYobisuKIdWiFZUljYKuGCcK3FWvDvobqdVbtLmXqIZ9Da60cQ7HYzTf794t9HrsNNSSpXHkQUW9wIxfJsAkx4dWhgG4yFMqHkla6qaPMOMvvwHvQ1T9Lk9zWuWq1atqjLFD5SNATFCfyyGUT1bQh8sobMl9N4Seq7ixZ9tHEN-eSAD4gDgdh4UxN-5_yP7EzHkwyU</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2511579894</pqid></control><display><type>article</type><title>Expert consensus on the safety prevention and control of nuclear medicine diagnosis and treatment during the outbreak of COVID-19 (1st edition): (translated from Chinese version)</title><source>MEDLINE</source><source>SpringerNature Journals</source><creator>Lan, Xiaoli ; Long, Yu ; Shao, Fuqiang ; Song, Yangminghui</creator><creatorcontrib>Lan, Xiaoli ; Long, Yu ; Shao, Fuqiang ; Song, Yangminghui</creatorcontrib><description>In December 2019, an infectious disease caused by a new type of coronavirus infection was prevalent in Wuhan and across the country. On January 20, 2020, the National Health Commission of the People’s Republic of China issued No.1 Announcement, which incorporated the novel coronavirus pneumonia into the Class B infectious disease according to the Law on Prevention and Control of Infectious Disease, but the disease should be adopted in the management of Class A infectious disease. In order to effectively control the source of infection, cut off the transmission route, protect the susceptible population, ensure the medical quality and medical safety, perform epidemic prevention and control, and comprehensively guarantee the life safety and physical health of medical staff, patients, and family members, it is very important to organize and carry out nuclear medicine diagnosis and treatment scientifically and safely. According to the national prevention and control policy, Chinese Society of Nuclear Medicine and editorial board of the
Chinese Journal of Nuclear Medicine and Molecular Imaging
organized professionals to formulate the expert consensus on the safety prevention process of nuclear medicine imaging and nuclide therapy during the period of new coronavirus infection.</description><identifier>ISSN: 1619-7070</identifier><identifier>EISSN: 1619-7089</identifier><identifier>DOI: 10.1007/s00259-020-04900-0</identifier><identifier>PMID: 33394078</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>Cardiology ; China - epidemiology ; Consensus ; Coronaviridae ; Coronaviruses ; COVID-19 ; COVID-19 - prevention & control ; Diagnosis ; Disease control ; Disease Outbreaks - prevention & control ; Disease prevention ; Disease transmission ; Epidemics ; Guidelines ; Health services ; Humans ; Imaging ; Infection and inflammation ; Infections ; Infectious diseases ; Medical diagnosis ; Medical imaging ; Medical personnel ; Medicine ; Medicine & Public Health ; Nuclear engineering ; Nuclear Medicine ; Nuclear Medicine - trends ; Nuclear safety ; Oncology ; Orthopedics ; Radiology ; Safety ; SARS-CoV-2</subject><ispartof>European journal of nuclear medicine and molecular imaging, 2021-04, Vol.48 (4), p.1134-1143</ispartof><rights>The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2021</rights><rights>The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2021.</rights><rights>The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2021</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c532t-6cc99b8854ced875b16e3157fd775c3332666392c42302e833834c069e2312293</citedby><cites>FETCH-LOGICAL-c532t-6cc99b8854ced875b16e3157fd775c3332666392c42302e833834c069e2312293</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00259-020-04900-0$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00259-020-04900-0$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>230,314,780,784,885,27924,27925,41488,42557,51319</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33394078$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lan, Xiaoli</creatorcontrib><creatorcontrib>Long, Yu</creatorcontrib><creatorcontrib>Shao, Fuqiang</creatorcontrib><creatorcontrib>Song, Yangminghui</creatorcontrib><title>Expert consensus on the safety prevention and control of nuclear medicine diagnosis and treatment during the outbreak of COVID-19 (1st edition): (translated from Chinese version)</title><title>European journal of nuclear medicine and molecular imaging</title><addtitle>Eur J Nucl Med Mol Imaging</addtitle><addtitle>Eur J Nucl Med Mol Imaging</addtitle><description>In December 2019, an infectious disease caused by a new type of coronavirus infection was prevalent in Wuhan and across the country. On January 20, 2020, the National Health Commission of the People’s Republic of China issued No.1 Announcement, which incorporated the novel coronavirus pneumonia into the Class B infectious disease according to the Law on Prevention and Control of Infectious Disease, but the disease should be adopted in the management of Class A infectious disease. In order to effectively control the source of infection, cut off the transmission route, protect the susceptible population, ensure the medical quality and medical safety, perform epidemic prevention and control, and comprehensively guarantee the life safety and physical health of medical staff, patients, and family members, it is very important to organize and carry out nuclear medicine diagnosis and treatment scientifically and safely. According to the national prevention and control policy, Chinese Society of Nuclear Medicine and editorial board of the
Chinese Journal of Nuclear Medicine and Molecular Imaging
organized professionals to formulate the expert consensus on the safety prevention process of nuclear medicine imaging and nuclide therapy during the period of new coronavirus infection.</description><subject>Cardiology</subject><subject>China - epidemiology</subject><subject>Consensus</subject><subject>Coronaviridae</subject><subject>Coronaviruses</subject><subject>COVID-19</subject><subject>COVID-19 - prevention & control</subject><subject>Diagnosis</subject><subject>Disease control</subject><subject>Disease Outbreaks - prevention & control</subject><subject>Disease prevention</subject><subject>Disease transmission</subject><subject>Epidemics</subject><subject>Guidelines</subject><subject>Health services</subject><subject>Humans</subject><subject>Imaging</subject><subject>Infection and inflammation</subject><subject>Infections</subject><subject>Infectious diseases</subject><subject>Medical diagnosis</subject><subject>Medical imaging</subject><subject>Medical personnel</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Nuclear engineering</subject><subject>Nuclear Medicine</subject><subject>Nuclear Medicine - trends</subject><subject>Nuclear safety</subject><subject>Oncology</subject><subject>Orthopedics</subject><subject>Radiology</subject><subject>Safety</subject><subject>SARS-CoV-2</subject><issn>1619-7070</issn><issn>1619-7089</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNp9kk1v1DAQhiMEoqXwBzggS1yWQ8AfSRxzQEJLWypV6gW4Wl5nsuuS2IvHWdG_xS_E2S3Lx4GLbdnPvDPjeYviOaOvGaXyDVLKa1VSTktaKZrXB8Upa5gqJW3Vw-NZ0pPiCeItpazlrXpcnAghVEVle1r8OP--hZiIDR7B44QkeJI2QND0kO7INsIOfHL51vhuxlIMAwk98ZMdwEQyQues80A6Z9Y-oMM9mSKYNOZQ0k3R-fVeNExple-_zvHLmy9XH0qmyIJhIllkTvLqLVmkaDwOJkFH-hhGstxkdQSyg4gz8rR41JsB4dn9flZ8vjj_tPxYXt9cXi3fX5e2FjyVjbVKrdq2rix0raxXrAHBatl3UtY2_wBvmkYobisuKIdWiFZUljYKuGCcK3FWvDvobqdVbtLmXqIZ9Da60cQ7HYzTf794t9HrsNNSSpXHkQUW9wIxfJsAkx4dWhgG4yFMqHkla6qaPMOMvvwHvQ1T9Lk9zWuWq1atqjLFD5SNATFCfyyGUT1bQh8sobMl9N4Seq7ixZ9tHEN-eSAD4gDgdh4UxN-5_yP7EzHkwyU</recordid><startdate>20210401</startdate><enddate>20210401</enddate><creator>Lan, Xiaoli</creator><creator>Long, Yu</creator><creator>Shao, Fuqiang</creator><creator>Song, Yangminghui</creator><general>Springer Berlin Heidelberg</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20210401</creationdate><title>Expert consensus on the safety prevention and control of nuclear medicine diagnosis and treatment during the outbreak of COVID-19 (1st edition): (translated from Chinese version)</title><author>Lan, Xiaoli ; Long, Yu ; Shao, Fuqiang ; Song, Yangminghui</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c532t-6cc99b8854ced875b16e3157fd775c3332666392c42302e833834c069e2312293</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Cardiology</topic><topic>China - epidemiology</topic><topic>Consensus</topic><topic>Coronaviridae</topic><topic>Coronaviruses</topic><topic>COVID-19</topic><topic>COVID-19 - prevention & control</topic><topic>Diagnosis</topic><topic>Disease control</topic><topic>Disease Outbreaks - prevention & control</topic><topic>Disease prevention</topic><topic>Disease transmission</topic><topic>Epidemics</topic><topic>Guidelines</topic><topic>Health services</topic><topic>Humans</topic><topic>Imaging</topic><topic>Infection and inflammation</topic><topic>Infections</topic><topic>Infectious diseases</topic><topic>Medical diagnosis</topic><topic>Medical imaging</topic><topic>Medical personnel</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Nuclear engineering</topic><topic>Nuclear Medicine</topic><topic>Nuclear Medicine - trends</topic><topic>Nuclear safety</topic><topic>Oncology</topic><topic>Orthopedics</topic><topic>Radiology</topic><topic>Safety</topic><topic>SARS-CoV-2</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lan, Xiaoli</creatorcontrib><creatorcontrib>Long, Yu</creatorcontrib><creatorcontrib>Shao, Fuqiang</creatorcontrib><creatorcontrib>Song, Yangminghui</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Neurosciences Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies & Aerospace Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biological Science Database</collection><collection>Nursing & Allied Health Premium</collection><collection>Advanced Technologies & Aerospace Database</collection><collection>ProQuest Advanced Technologies & Aerospace Collection</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>European journal of nuclear medicine and molecular imaging</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lan, Xiaoli</au><au>Long, Yu</au><au>Shao, Fuqiang</au><au>Song, Yangminghui</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Expert consensus on the safety prevention and control of nuclear medicine diagnosis and treatment during the outbreak of COVID-19 (1st edition): (translated from Chinese version)</atitle><jtitle>European journal of nuclear medicine and molecular imaging</jtitle><stitle>Eur J Nucl Med Mol Imaging</stitle><addtitle>Eur J Nucl Med Mol Imaging</addtitle><date>2021-04-01</date><risdate>2021</risdate><volume>48</volume><issue>4</issue><spage>1134</spage><epage>1143</epage><pages>1134-1143</pages><issn>1619-7070</issn><eissn>1619-7089</eissn><abstract>In December 2019, an infectious disease caused by a new type of coronavirus infection was prevalent in Wuhan and across the country. On January 20, 2020, the National Health Commission of the People’s Republic of China issued No.1 Announcement, which incorporated the novel coronavirus pneumonia into the Class B infectious disease according to the Law on Prevention and Control of Infectious Disease, but the disease should be adopted in the management of Class A infectious disease. In order to effectively control the source of infection, cut off the transmission route, protect the susceptible population, ensure the medical quality and medical safety, perform epidemic prevention and control, and comprehensively guarantee the life safety and physical health of medical staff, patients, and family members, it is very important to organize and carry out nuclear medicine diagnosis and treatment scientifically and safely. According to the national prevention and control policy, Chinese Society of Nuclear Medicine and editorial board of the
Chinese Journal of Nuclear Medicine and Molecular Imaging
organized professionals to formulate the expert consensus on the safety prevention process of nuclear medicine imaging and nuclide therapy during the period of new coronavirus infection.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><pmid>33394078</pmid><doi>10.1007/s00259-020-04900-0</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1619-7070 |
| ispartof | European journal of nuclear medicine and molecular imaging, 2021-04, Vol.48 (4), p.1134-1143 |
| issn | 1619-7070 1619-7089 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7779900 |
| source | MEDLINE; SpringerNature Journals |
| subjects | Cardiology China - epidemiology Consensus Coronaviridae Coronaviruses COVID-19 COVID-19 - prevention & control Diagnosis Disease control Disease Outbreaks - prevention & control Disease prevention Disease transmission Epidemics Guidelines Health services Humans Imaging Infection and inflammation Infections Infectious diseases Medical diagnosis Medical imaging Medical personnel Medicine Medicine & Public Health Nuclear engineering Nuclear Medicine Nuclear Medicine - trends Nuclear safety Oncology Orthopedics Radiology Safety SARS-CoV-2 |
| title | Expert consensus on the safety prevention and control of nuclear medicine diagnosis and treatment during the outbreak of COVID-19 (1st edition): (translated from Chinese version) |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T12%3A52%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Expert%20consensus%20on%20the%20safety%20prevention%20and%20control%20of%20nuclear%20medicine%20diagnosis%20and%20treatment%20during%20the%20outbreak%20of%20COVID-19%20(1st%20edition):%20(translated%20from%20Chinese%20version)&rft.jtitle=European%20journal%20of%20nuclear%20medicine%20and%20molecular%20imaging&rft.au=Lan,%20Xiaoli&rft.date=2021-04-01&rft.volume=48&rft.issue=4&rft.spage=1134&rft.epage=1143&rft.pages=1134-1143&rft.issn=1619-7070&rft.eissn=1619-7089&rft_id=info:doi/10.1007/s00259-020-04900-0&rft_dat=%3Cproquest_pubme%3E2475096259%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2511579894&rft_id=info:pmid/33394078&rfr_iscdi=true |